[6-K] Golden Sun Health Technology Group Limited Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Golden Sun Health Technology Group Limited furnished a Form 6-K that is incorporated by reference into its effective Form F-1 registration statement. The filing states that Unaudited Condensed Consolidated Financial Statements as of March 31, 2025 and for the six months ended March 31, 2025 and 2024 are attached as Exhibit 99.1, and that an Operating and Financial Review and Prospects for the same periods is attached as Exhibit 99.2.

The report contains a detailed cautionary statement about forward-looking statements and lists key risk assumptions including financial projections, growth and expansion execution, economic and political conditions, capital requirements, talent retention, competition in the education industry, and other assumptions. The document is signed on the company’s behalf by its Chief Executive Officer.

Positive

• Provides transparency by attaching unaudited condensed consolidated financial statements (Exhibit 99.1) for the six months ended March 31, 2025 and 2024.
• Includes management review via an Operating and Financial Review and Prospects (Exhibit 99.2), indicating management furnished narrative context alongside the financials.
• Uses Inline XBRL (Exhibits 101.*) for structured financial data, facilitating machine-readable review.

Negative

• No financial metrics in the body of this Form 6-K; detailed figures and ratios are not presented here and must be read in the attached exhibits.
• Forward-looking statements subject to many risks as enumerated in the filing, including assumptions about growth, capital needs, economic conditions, competition, and talent retention.

Insights

Financial Analyst

TL;DR: Routine Form 6-K provides interim financials and MD&A; substantive numbers reside in attached exhibits.

The filing notifies investors that the company furnished unaudited condensed consolidated financial statements and an operating and financial review for the six-month period ending March 31, 2025, incorporated into its F-1 registration. The primary content here is procedural: identification of exhibits and an explicit forward-looking caution outlining assumptions and risks. No performance metrics or balance sheet details appear in the body of this report; those must be reviewed in Exhibit 99.1 and 99.2 for material analysis.

Corporate Governance Expert

TL;DR: Filing reflects compliance and disclosure of forward-looking risk framework, but the report itself contains no financial detail.

The document demonstrates formal disclosure practices by incorporating interim financial statements and an operating review into the public record and by including a comprehensive forward-looking statements caution. The exhibit index identifies Inline XBRL tags, which supports structured data delivery. Because the text does not include the actual financial figures or management discussion, material assessment of operational performance requires consulting the attached exhibits.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-41425

Golden Sun Health Technology Group Limited 

金太阳健康科技集团有限公司

(Translation of registrant’s name into English)

Room 503, Building C2, No. 1599

Xinjinqiao Road, Pudong New Area

Shanghai, China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

INCORPORATION BY REFERENCE

This report on Form 6-K (“Report”) shall be deemed to be incorporated by reference into the registration statement on Form F-1, as amended (Registration Number: 333-285857) of Golden Sun Health Technology Group Limited, a Cayman Islands exempted company (the “Company”), declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on March 25, 2025 (“Registration Statement”), and into each prospectus or prospectus supplement outstanding under the Registration Statement, to the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

Attached as Exhibit 99.1 to this Report are the Unaudited Condensed Consolidated Financial Statements of the Company as of March 31, 2025 and for the Six Months Ended March 31, 2025 and 2024, respectively.

Attached as Exhibit 99.2 to this Report is the Operating and Financial Review and Prospects of the Company for the Six Months Ended March 31, 2025 and 2024, respectively.

1

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This Form 6-K Report and the exhibits hereto contain certain forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “approximates,” “assesses,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or similar expressions.

Many of these statements are based on our assumptions about factors that are beyond our ability to control or predict and are subject to significant risks and uncertainties that are described more fully in “Item 3. Key Information—D. Risk Factors” on our annual report on Form 20-F filed with the SEC on February 14, 2025. Any of these factors or a combination of these factors could materially affect our future results of operations and the ultimate accuracy of the forward-looking statements. Fluctuations in our future financial results may negatively impact the value of our Class A ordinary shares. In addition to these important factors, important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include, among other things:

● assumptions about our future financial and operating results, including revenue, income, expenditures, cash balances, and other financial items;

● our ability to execute our growth, and expansion, including our ability to meet our goals;

● current and future economic and political conditions;

● our capital requirements and our ability to raise any additional financing which we may require;

● our ability to attract clients and further enhance our brand recognition;

● our ability to hire and retain qualified management personnel and key employees in order to enable us to develop our business;

● trends and competition in the education industry;

● other assumptions described in this Report underlying or relating to any forward-looking statements.

Should one or more of the foregoing risks or uncertainties materialize, should any of our assumptions prove incorrect, or should we be unable to address any of the foregoing factors, our actual results may vary in material and adverse respects from those projected in these forward-looking statements. Consequently, there can be no assurance that actual results or developments anticipated by us will be realized or, even if substantially realized, that they will have the expected consequences to, or effects, on us. Given these uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements.

The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s annual report and other filings with the U.S. Securities and Exchange Commission. As a result, you are cautioned not to rely on any forward-looking statements.

2

EXHIBIT INDEX

Exhibit Number		Description
99.1		Unaudited Condensed Consolidated Financial Statements of the Company as of March 31, 2025 and for the Six Months Ended March 31, 2025 and 2024.
99.2		Operating and Financial Review and Prospects of the Company for the Six Months Ended March 31, 2025 and 2024.
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Golden Sun Health Technology Group Limited
	By:	/s/ Xueyuan Weng
		Name:	Xueyuan Weng
		Title:	Chief Executive Officer

Date: August 8, 2025

4

FAQ

What did GSUN file in this Form 6-K?

The company attached Unaudited Condensed Consolidated Financial Statements (Exhibit 99.1) and an Operating and Financial Review and Prospects (Exhibit 99.2) for the six months ended March 31, 2025 and 2024.

Is this Form 6-K incorporated into GSUN's registration statement?

Yes. The Report states it is incorporated by reference into the company’s effective Form F-1 registration (No. 333-285857) to the extent not superseded.

Does the Form 6-K include forward-looking statements?

Yes. The filing contains a cautionary statement about forward-looking statements and lists specific risk assumptions that could affect future results.

Where are the detailed financial numbers for GSUN’s six-month period?

Detailed figures are contained in Exhibit 99.1 (unaudited condensed consolidated financial statements); the Form 6-K body does not present those numbers.

Who authorized and signed the Form 6-K for GSUN?

The document is signed on behalf of Golden Sun Health Technology Group Limited by Chief Executive Officer Xueyuan Weng.